Category: Finance
Moderna's shares surged over 10% following the first reported bird-flu death in the U.S., as the company develops a vaccine for H5N1. Despite the recent gain, the stock has lost over half its value in the past year.
Keywords: Moderna, H5N1, bird flu
Update At: 1/8/2025